Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 20;102(3):e32698.
doi: 10.1097/MD.0000000000032698.

High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review

Affiliations
Review

High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review

Huihui Chen et al. Medicine (Baltimore). .

Abstract

Rationale: Anti-glomerular basement membrane (anti-GBM) disease has been reported to coexist with other immune-mediated glomerular disorders, including antineutrophil cytoplasmic autoantibody positive glomerulonephritis and membranous glomerulopathy. It is well known that anti-GBM disease often manifests as type I crescentic glomerulonephritis on renal biopsy. However, concurrent cases of both type I crescentic glomerulonephritis and IgA nephropathy are rare.

Patient concerns: We report the case of a 40-years-old woman with microscopic hematuria, mild proteinuria and an immunocompromised status. Laboratory data revealed serum creatinine showed progressive progress, suddenly rising from the normal range to 316.2μmol/L within 4 months. The CD4 lymphocyte count was 0.274 × 109/L (reference value 0.35-1.82 × 109/L). The anti-GBM antibody titer was 192.4 IU/mL (reference range: <20 RU/mL).

Diagnoses: Renal biopsy was performed after admission. The pathological diagnosis was type I crescentic glomerulonephritis, IgA nephropathy, and clinical anti-GBM disease.

Interventions: The patient was seriously ill on admission and progressed rapidly. Combined with poor immune function, we immediately initiated high-frequency plasma exchange (PE). In addition, to avoid rebound of antibody levels, PE was performed for 5 times. Follow-up treatment was combined with standard-dose corticosteroids and cyclophosphamide.

Outcomes: The patient was followed up for 1 year. On the last visit, her serum creatinine decreased to 103.5μmol/L, anti-GBM antibody remained negative, and proteinuria and hematuria disappeared.

Lessons: This case illustrates that when crescentic nephritis or anti-GBM disease is combined with other immune diseases, especially when the immune function is extremely low, if the application of high-dose steroid shocks may induce fatal infections, to some extent high frequency PE has certain advantages.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Renal biopsy findings. (a). Direct immunofluorescence analysis showed strong (+++) linear staining along the capillary loop for IgG (×200). (b) Direct immunofluorescence analysis showed strong (+++) granular staining along the mesangium for IgA (×200). (c–d) Light microscopy of renal puncture tissue revealed the formation of large crescents, the pathological manifestations were dominated by cellular crescents (×400). (e–f) Electron microscopic photograph of the renal biopsy, showing the electron-dense deposits in mesangial areas (×6000). IgG = immunoglobulin G.
Figure 2.
Figure 2.
The patient’s renal function during hospitalization. Serum creatinine (μmol/L) and blood urea nitrogen (mmol/L) by hospital day. BUN = blood urea nitrogen, CD4 = T4 lymphocyte counts, CD20 = B lymphocytic counts, IgG = immunoglobulin G, PLEX = plasma exchange, SCr = serum creatinine.

Similar articles

Cited by

References

    1. Parmar MS, Khalid B. Crescentic Glomerulonephritis. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2022.
    1. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162–72. - PMC - PubMed
    1. Kojima T, Hirose G, Komatsu S, et al. . Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report. BMC Nephrol. 2019;20:25. - PMC - PubMed
    1. Zhang M, Yang D, Wang W, et al. . Pneumocystis pneumonia secondary to intensive immunosuppression treatment for anti-GBM disease complicated with IgA nephropathy: a case report and literature review. Medicine (Baltim). 2021;100:e27728. - PMC - PubMed
    1. Trpkov K, Abdulkareem F, Jim K, et al. . Recurrence of anti-GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathy. Clin Nephrol. 1998;49:124–8. - PubMed

MeSH terms